Drug Discovery
-
High activity,
High selectivity -
High permeability,
Low system residue -
Local precision
drug delivery
Product Pipeline
Stage |
Project |
Indications |
Preclinical |
IND |
Clinical phase Ia |
Clinical phase Ib/II |
Clinical phase III |
Clinical stage | QY201 |
Psoriasis (moderate to severe), atopic dermatitis, alopecia areata, etc |
|
||||
QY201 |
Psoriasis (moderate to severe), atopic dermatitis, alopecia areata, etc |
|
|||||
QY201 |
Psoriasis (moderate to severe), atopic dermatitis, alopecia areata, etc |
|
|||||
QY101 |
Atopic dermatitis (mild to moderate,including children) Psoriasis, etc |
|
|||||
QY211 |
Psoriasis (mild to moderate), atopic dermatitis,vitiligo, etc |
|
|||||
Preclinical stage | QY301 | Ulcerative Colitis,Crohn's disease, etc |
|
||||
QY401 | Respiratory related indications |
|
- Clinical stage
- IND stage
- Preclinical stage